Results of the COVAD study showed that three-quarters of patients with rheumatoid arthritis reported adverse events related the COVID-19 vaccination; however, the majority of them were minor in severity.
Latika Gupta, MD, a rheumatologist and clinical immunologist at the Royal Wolverhampton Hospitals NHS Trust and University of Manchester, UK, and Mrinalini Dey, MD, from the department of rheumatology at the Queen Elizabeth Hospital in London, discuss the study findings in detail.
Read the full transcript here.
Assessing the Asthma Management Guideline Updates
Linda Bernstein, Pharm.D.Peer